Arformoterol Tartrate Solution
Product Images NDC 72266-259

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 72266-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Vial Carton Label (30s Carton Label)

Carton packaging for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Fosun Pharma USA Inc. Contains 30 sterile unit-dose vials, 2 mL each. Labels state to keep refrigerated or store at room temperature up to 6 weeks and to keep out of reach of children. Designed for oral inhalation use only.*

FDA Label Image

4vial Pouch (4units Pouch)

Arformoterol tartrate 15 mcg/2 mL inhalation solution label for four 2 mL sterile unit-dose vials. The label includes storage instructions, dosage form, and manufacturer Fosun Pharma USA Inc. It also features barcodes and notes that the product is for prescription use only.*

FDA Label Image

60 Vial Carton Label (60s Carton Label)

Arformoterol tartrate inhalation solution 15 mcg/2 mL carton label for 60 single-use vial pack. The label is for a respiratory inhalation solution distributed by Fosun Pharma USA Inc. It includes storage instructions to keep refrigerated or at room temperature for up to 6 weeks and states it is for oral inhalation only. The label also displays the NDC 72266-259 and a barcode.*

FDA Label Image

Figure (Aformoterol 01)

Chemical structure of Arformoterol tartrate showing the molecular arrangement of the active ingredient with attached tartrate salt.*

FDA Label Image

Figure 1 (Aformoterol 02)

A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose for two groups: placebo and 15 mcg Arformoterol tartrate. The graph plots hours postdose on the x-axis and mean FEV1 change on the y-axis, comparing respiratory inhalation solution effects.*

FDA Label Image

Figure 2 (Aformoterol 03)

Line graph showing mean change from baseline FEV1 (L) over 12 hours postdose comparing placebo and 15 mcg arformoterol tartrate BID. The graph includes data points for both treatments with placebo showing minimal change and arformoterol showing a peak increase followed by a gradual decline.*

FDA Label Image

Figure 1 (Aformoterol 05)

An instructional diagram showing a hand holding an inhalation device or vial with an arrow indicating a twisting or turning motion at the top, likely demonstrating how to open or activate the device.*

FDA Label Image

Figure 2 (Aformoterol 06)

An instructional diagram showing a hand inserting a small packet into a labeled reservoir, likely illustrating how to add or activate a solution for respiratory inhalation use.*

FDA Label Image

Figure 3 (Aformoterol 07)

An illustration showing the mouthpiece component of a respiratory inhalation device, labeled 'MOUTHPIECE.' The diagram highlights this part of the inhaler used to deliver the solution dose.*

FDA Label Image

Figure 4 (Aformoterol 08)

An instructional illustration showing a face mask connected to a respiratory solution delivery device. The image is likely intended to guide the correct attachment or use of the face mask for inhalation therapy.*

FDA Label Image

Figure 5 (Aformoterol 09)

Illustration showing a connection between a compressor device and tubing, presumably for use with respiratory treatments. The diagram highlights the compressor and the tubing attachment point without specific product branding or additional details.*

FDA Label Image

Figure 6 (Aformoterol 10)

An instructional illustration showing a person using a respiratory inhalation device, placing the mouthpiece of the device into their mouth for inhalation. The hand is holding the device, demonstrating the proper technique for administration.*

FDA Label Image

Single Vial Pouch Label (Single Pouch)

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL label for a sterile unit-dose vial. The label includes dosage strength, usage instructions to open foil pouch prior to administration, storage instructions, and manufacturer information for Fosun Pharma USA Inc. The label also features barcode and NDC 72266-259-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.